CD3 Monoclonal Antibody (OKT3), eBioscience
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0452177
- Awardee
- LIFE TECHNOLOGIES CORPORATION
- Contracting organization
- University of Virginia
- Cumulative value
- $132.00
About this award
The University of Virginia awarded contract A207_PO-0452177 to Life Technologies Corporation on July 11, 2026, for the procurement of laboratory reagents. The primary deliverable consists of CD3 Monoclonal Antibody (OKT3) manufactured by eBioscience, with an order quantity of 132 units at a unit price of $1.00 per unit. The contract cumulative value totals $132.00.
The procurement was executed within the Commonwealth of Virginia under the contracting authority of the University of Virginia. Performance of this contract involves delivery to the buyer at the University of Virginia's location. No specific performance period beyond the award date of July 11, 2026, is documented in the available contract materials. Life Technologies Corporation served as the prime contractor responsible for fulfilling all obligations under this purchase order.
Line items
| Item | Total |
|---|---|
| CD3 Monoclonal Antibody (OKT3), eBioscience | $132.00 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0452177?
Contract A207_PO-0452177 was awarded to LIFE TECHNOLOGIES CORPORATION by University of Virginia on July 11, 2026.
How much is contract A207_PO-0452177 worth?
Its cumulative value is $132.00.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award